Answers are grounded in this paper and cite their sources.
Metastatic breast cancer is considered incurable. Data regarding how patients with oligometastatic breast cancer might best be treated is limited, with questions concerning the role of locoregional treatment, inclusive of surgery and radiotherapy, and local treatment to the metastatic site. Here we present a case of a 42-year-old woman with oligometastatic HR+/HER2- breast cancer, who achieved a complete radiological response for the metastatic site, after receiving ribociclib and undergoing breast surgery. We review the current evidence for locoregional treatment, and discuss the role of cyclin inhibitors in systemic treatment.
No takes yet. Share an insight, caveat, or question.
Koh et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: